Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 4/2014

01.04.2014 | Original Article

Laparoscopic Total Mesorectal Excision for Extraperitoneal Rectal Cancer: Long-Term Results of a 18-Year Single-Centre Experience

verfasst von: Riccardo Brachet Contul, Manuela Grivon, Massimiliano Fabozzi, Paolo Millo, Mario Junior Nardi, Stefania Aimonetto, Umberto Parini, Rosaldo Allieta

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Background and Objectives

The oncologic efficacy of laparoscopic total mesorectal excision (TME) for middle–low rectal cancer is still under discussion because of the few long-term data. This study reports the results arising from a single-institution experience during a 18-year period.

Methods

Data about 132 consecutive laparoscopic TME performed between January 1994 and January 2012 were analysed with Kaplan–Meier method and a uni- and multi-variate analysis was conducted to define independent survival predictors.

Results

A total of 116 sphincter-preserving operations and 16 abdominoperineal resections were performed. Postoperative mortality and morbidity were 0.8 and 18.2 %, with a rate of anastomotic leakage of 13.8 %. Average follow-up was 85.9 months (range 13–210). Actuarial local recurrence rate was 4.13 % at 5 years (any pelvic recurrence developed after 3 years from surgery). Overall and disease-free survival was respectively 83 and 79.8 % at 5 years, 71 and 73 % at 10 years and then remained constant until 18 years. Survival was correlated only to tumour stage and the type of surgery.

Conclusions

Laparoscopic TME for extraperitoneal rectal cancer shows long-term oncologic outcomes similar to open rectal resections.
Literatur
1.
Zurück zum Zitat The Colon Cancer Laparoscopic or Open Resection Study group (COLOR) (2005) Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 6: 477–84CrossRef The Colon Cancer Laparoscopic or Open Resection Study group (COLOR) (2005) Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 6: 477–84CrossRef
2.
Zurück zum Zitat Fleshman J, Sargent DJ, Green E,Anvari M, Stryker SJ, Beart RW Jr, Hellinger M, Flanagan R, Peters W, Nelson H, for the Clinical Outcomes of Surgical Therapy Study Group. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group. Ann Surg 2007;246: 655–62.PubMedCrossRef Fleshman J, Sargent DJ, Green E,Anvari M, Stryker SJ, Beart RW Jr, Hellinger M, Flanagan R, Peters W, Nelson H, for the Clinical Outcomes of Surgical Therapy Study Group. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group. Ann Surg 2007;246: 655–62.PubMedCrossRef
3.
Zurück zum Zitat Reza MM, Blasco JA, Andradas E, Cantero R, Mayol J. Systematic review of laparoscopic versus open surgery for colorectal cancer. Br J Surg 2006; 93:921–8.PubMedCrossRef Reza MM, Blasco JA, Andradas E, Cantero R, Mayol J. Systematic review of laparoscopic versus open surgery for colorectal cancer. Br J Surg 2006; 93:921–8.PubMedCrossRef
4.
Zurück zum Zitat Kuhry E, Schwenk WF, Gaupset R, Romild U, Bonjer HJ. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev 2008; 16: CD003432. Kuhry E, Schwenk WF, Gaupset R, Romild U, Bonjer HJ. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev 2008; 16: CD003432.
5.
Zurück zum Zitat Green BL, Marshall HC, Collinson F, Quirke P, Guillou P, Jayne DG, Brown M. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg 2013; 100: 75–82.PubMedCrossRef Green BL, Marshall HC, Collinson F, Quirke P, Guillou P, Jayne DG, Brown M. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg 2013; 100: 75–82.PubMedCrossRef
6.
Zurück zum Zitat Heald RJ, Moran BJ, Ryall RDH, Sexton R, MacFarlane JK. Rectal Cancer. The Basingstoke experience of total mesorectal excision, 1978–1997. Arch. Surg. 1998; 133:894–899.PubMedCrossRef Heald RJ, Moran BJ, Ryall RDH, Sexton R, MacFarlane JK. Rectal Cancer. The Basingstoke experience of total mesorectal excision, 1978–1997. Arch. Surg. 1998; 133:894–899.PubMedCrossRef
7.
Zurück zum Zitat Cheung HYS, Ng KH, Leung AL, Chung CC, Yau KK, Li MK. Laparoscopic sphincter-preserving total mesorectal excision: 10-year report. Colorectal Dis. 2011; 13: 627–31.PubMedCrossRef Cheung HYS, Ng KH, Leung AL, Chung CC, Yau KK, Li MK. Laparoscopic sphincter-preserving total mesorectal excision: 10-year report. Colorectal Dis. 2011; 13: 627–31.PubMedCrossRef
8.
Zurück zum Zitat Laurent C, Leblanc F, Wütrich P, Scheffler M, Rullier E. Laparoscopic versus open surgery for rectal cancer. Long-term oncologic result. Ann. Surg. 2009; 250: 54–61.PubMedCrossRef Laurent C, Leblanc F, Wütrich P, Scheffler M, Rullier E. Laparoscopic versus open surgery for rectal cancer. Long-term oncologic result. Ann. Surg. 2009; 250: 54–61.PubMedCrossRef
9.
Zurück zum Zitat van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, Bonjer HJ; COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013; 14(3):210–18.PubMedCrossRef van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, Bonjer HJ; COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013; 14(3):210–18.PubMedCrossRef
11.
Zurück zum Zitat Kehlet H: Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Surg 1997; 78: 606–17. Kehlet H: Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Surg 1997; 78: 606–17.
12.
Zurück zum Zitat Kehlet H, Wilmore DW: Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 2008; 248; 2: 189–98.PubMedCrossRef Kehlet H, Wilmore DW: Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 2008; 248; 2: 189–98.PubMedCrossRef
13.
Zurück zum Zitat Dindo D, Demartines M, Clavien P-A: Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004; 240: 205–213.PubMedCentralPubMedCrossRef Dindo D, Demartines M, Clavien P-A: Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004; 240: 205–213.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Heald RJ, Husband EM, Ryall RDH. The mesorectum in rectal cancer surgery. The clue to pelvic recurrence? Br J Surg 1982; 69: 613–616.PubMedCrossRef Heald RJ, Husband EM, Ryall RDH. The mesorectum in rectal cancer surgery. The clue to pelvic recurrence? Br J Surg 1982; 69: 613–616.PubMedCrossRef
15.
Zurück zum Zitat Peeters KCMJ, Marijnen CAM, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CHJ. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann. Surg. 2007; 246: 693–701PubMedCrossRef Peeters KCMJ, Marijnen CAM, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CHJ. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann. Surg. 2007; 246: 693–701PubMedCrossRef
16.
Zurück zum Zitat Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau JH, Liersch T, Schmidberger H, Raab R. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 2004; 351: 1731–1740.PubMedCrossRef Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau JH, Liersch T, Schmidberger H, Raab R. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 2004; 351: 1731–1740.PubMedCrossRef
17.
Zurück zum Zitat Kapitejin E, Marijen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, Krieken JH, van Leer JW, van de Velde CJ. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 2001; 345: 638–646.CrossRef Kapitejin E, Marijen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, Krieken JH, van Leer JW, van de Velde CJ. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 2001; 345: 638–646.CrossRef
18.
Zurück zum Zitat Jayne DG, Guillou PJ, Thorpe HC, Quirke P, Copeland J, Smith AMH, Heath RM, Brown JM. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 2007; 25: 3061–3068.PubMedCrossRef Jayne DG, Guillou PJ, Thorpe HC, Quirke P, Copeland J, Smith AMH, Heath RM, Brown JM. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 2007; 25: 3061–3068.PubMedCrossRef
19.
Zurück zum Zitat Merkel S, Mansmann U, Hohenberger W, Hermanek P. Time to locoregional recurrence after curative resection of rectal carcinoma is prolonged after neoadjuvant treatment: a systematic review and meta-analysis. Colorect. Dis. 2010; 13: 123–131.CrossRef Merkel S, Mansmann U, Hohenberger W, Hermanek P. Time to locoregional recurrence after curative resection of rectal carcinoma is prolonged after neoadjuvant treatment: a systematic review and meta-analysis. Colorect. Dis. 2010; 13: 123–131.CrossRef
20.
Zurück zum Zitat Bentzen SM, Balslev I, Pedersen M, Balslev I, Pedersen M, Teglbjaerg PS, Hanberg-Sørensen F, Bone J, Jacobsen NO, Sell A, Overgaard J, Bertelsen K. Time to locoregional recurrence after resection of Duke’s B and C colorectal cancer with or without adjuvant post-operative radiotherapy. A multivariate regression analysis. Br. J. Cancer 1992; 65: 102–107.PubMedCentralPubMedCrossRef Bentzen SM, Balslev I, Pedersen M, Balslev I, Pedersen M, Teglbjaerg PS, Hanberg-Sørensen F, Bone J, Jacobsen NO, Sell A, Overgaard J, Bertelsen K. Time to locoregional recurrence after resection of Duke’s B and C colorectal cancer with or without adjuvant post-operative radiotherapy. A multivariate regression analysis. Br. J. Cancer 1992; 65: 102–107.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat American Association for Public Opinion Research. Standard definitions: final dispositions of case codes and outcome rates for surveys. 7th ed. Lenexa, KS; revised 2011. American Association for Public Opinion Research. Standard definitions: final dispositions of case codes and outcome rates for surveys. 7th ed. Lenexa, KS; revised 2011.
22.
Zurück zum Zitat Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 2010; 97: 1638–1645.PubMedCrossRef Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 2010; 97: 1638–1645.PubMedCrossRef
23.
Zurück zum Zitat Sartori CC, Dal Pozzo A, Franzato B, Balduino M, Sartori A, Baiocchi GL. Laparoscopic total mesorectal excision for rectal cancer: experience of a single center with a series of 174 patients. Surg End 2011; 25:508–514.CrossRef Sartori CC, Dal Pozzo A, Franzato B, Balduino M, Sartori A, Baiocchi GL. Laparoscopic total mesorectal excision for rectal cancer: experience of a single center with a series of 174 patients. Surg End 2011; 25:508–514.CrossRef
26.
Zurück zum Zitat Dulucq JL, Wintringer P, Stabilini C, Mahajna A. Laparoscopic rectal resection with anal sphincter preservation for rectal cancer. Long-term outcome. Surg Endosc 2005; 19:1468–74.CrossRef Dulucq JL, Wintringer P, Stabilini C, Mahajna A. Laparoscopic rectal resection with anal sphincter preservation for rectal cancer. Long-term outcome. Surg Endosc 2005; 19:1468–74.CrossRef
27.
Zurück zum Zitat MacFarlane JK, Ryall RDH, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457–60.PubMedCrossRef MacFarlane JK, Ryall RDH, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457–60.PubMedCrossRef
28.
Zurück zum Zitat Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J. Am. Coll. Surg. 1995; 181: 335–346.PubMed Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J. Am. Coll. Surg. 1995; 181: 335–346.PubMed
29.
Zurück zum Zitat Heald RJ, Karanjia ND. Results of radical surgery for rectal cancer. World J. Surg. 1992; 16: 848–857.PubMedCrossRef Heald RJ, Karanjia ND. Results of radical surgery for rectal cancer. World J. Surg. 1992; 16: 848–857.PubMedCrossRef
31.
Zurück zum Zitat Li S, Chi P, Lin H, Lu X, Huang Y. Long-term outcomes of laparoscopic surgery versus open resection for middle and lower rectal cancer: an NTCLES study. Surg Endosc 2011; 25: 3175–3182.PubMedCrossRef Li S, Chi P, Lin H, Lu X, Huang Y. Long-term outcomes of laparoscopic surgery versus open resection for middle and lower rectal cancer: an NTCLES study. Surg Endosc 2011; 25: 3175–3182.PubMedCrossRef
32.
Zurück zum Zitat Asoglu O, Balik E, Kunduz E, Yamaner S, Akyz A, Gulluoglu M, Kapran Y, Bugra D. Laparoscopic surgery for rectal cancer: outcomes of 513 patients. World J. Surg. 2013; 37: 883–892.PubMedCrossRef Asoglu O, Balik E, Kunduz E, Yamaner S, Akyz A, Gulluoglu M, Kapran Y, Bugra D. Laparoscopic surgery for rectal cancer: outcomes of 513 patients. World J. Surg. 2013; 37: 883–892.PubMedCrossRef
33.
Zurück zum Zitat Moore E, Heald RJ, Cecil TD, Sharpe GD, Sexton R, Moran BJ. Almost all five year disease free survivors are cured following rectal cancer surgery, but longer term follow-up detects some late local and systemic recurrences. Colorect. Dis. 2005; 7: 403–405.CrossRef Moore E, Heald RJ, Cecil TD, Sharpe GD, Sexton R, Moran BJ. Almost all five year disease free survivors are cured following rectal cancer surgery, but longer term follow-up detects some late local and systemic recurrences. Colorect. Dis. 2005; 7: 403–405.CrossRef
34.
Zurück zum Zitat Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, Sebag-Montefiore DJ, Tekkis P, Brown G. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann. Surg. 2011; 253: 711–719CrossRef Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, Sebag-Montefiore DJ, Tekkis P, Brown G. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann. Surg. 2011; 253: 711–719CrossRef
35.
Zurück zum Zitat Roh MS, Colangelo LH, O’Connel MJ, Yothers G, Deutsch M, Allegra CJ, Kahlenberg MS, Baez-Diaz L, Ursiny CS, Petrelli NJ, Wolmark N. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J. Clin. Oncol. 2009; 27: 5124–5130.PubMedCentralPubMedCrossRef Roh MS, Colangelo LH, O’Connel MJ, Yothers G, Deutsch M, Allegra CJ, Kahlenberg MS, Baez-Diaz L, Ursiny CS, Petrelli NJ, Wolmark N. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J. Clin. Oncol. 2009; 27: 5124–5130.PubMedCentralPubMedCrossRef
37.
Zurück zum Zitat Lee JH, Kim SH, Kim JG, Cho HM, Shim BJ. Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes. Int. J. Radiation Oncoloy Biol. Phys. 2011, 81: 431–438.CrossRef Lee JH, Kim SH, Kim JG, Cho HM, Shim BJ. Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes. Int. J. Radiation Oncoloy Biol. Phys. 2011, 81: 431–438.CrossRef
40.
Zurück zum Zitat Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R, Jarnagin W, Blumgart L. Simultaneous liver and colorectal resection for metastatic colorectal cancer are safe for synchronous colorectal liver metastasis. J. Am. Coll. Surg. 2003; 197: 233–241.PubMedCrossRef Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R, Jarnagin W, Blumgart L. Simultaneous liver and colorectal resection for metastatic colorectal cancer are safe for synchronous colorectal liver metastasis. J. Am. Coll. Surg. 2003; 197: 233–241.PubMedCrossRef
42.
Zurück zum Zitat Siegel R, Cuesta A, Targarona E, Bader FG, Morino M, Corcelles R, Lacy AM, Pahlman L, Haglind E, Bujko K, Brich HP, Heiss MM, Eikermann M, Neugebauer EAM. Laparoscopic extraperitoneal rectal cancer surgery: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg. End. 2011; 25: 2423–244.CrossRef Siegel R, Cuesta A, Targarona E, Bader FG, Morino M, Corcelles R, Lacy AM, Pahlman L, Haglind E, Bujko K, Brich HP, Heiss MM, Eikermann M, Neugebauer EAM. Laparoscopic extraperitoneal rectal cancer surgery: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg. End. 2011; 25: 2423–244.CrossRef
43.
Zurück zum Zitat Li S, Chi P, Lin H, Lu X, Huang Y. Long-term outcomes of laparoscopic surgery versus open resection for middle and lower rectal cancer: an NTCLES study. Surg Endosc 2011; 25: 3175–3182.PubMedCrossRef Li S, Chi P, Lin H, Lu X, Huang Y. Long-term outcomes of laparoscopic surgery versus open resection for middle and lower rectal cancer: an NTCLES study. Surg Endosc 2011; 25: 3175–3182.PubMedCrossRef
45.
Zurück zum Zitat Lange MM, Martz JE, Ramdeen B, Brooks V, Boakie-Adjei K, Van de Velde CJH, Enker WE. Long-term results of rectal cancer surgery with a systematical operative approach. Ann. Surg. Oncol. 2013; DOI 10.1245/s10434-012-283-2.PubMed Lange MM, Martz JE, Ramdeen B, Brooks V, Boakie-Adjei K, Van de Velde CJH, Enker WE. Long-term results of rectal cancer surgery with a systematical operative approach. Ann. Surg. Oncol. 2013; DOI 10.1245/s10434-012-283-2.PubMed
46.
Zurück zum Zitat Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AMH, Heath RM, Brown JM. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC Trial): multicentre, randomized controlled trial. Lancet 2005; 365: 1718–26.PubMedCrossRef Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AMH, Heath RM, Brown JM. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC Trial): multicentre, randomized controlled trial. Lancet 2005; 365: 1718–26.PubMedCrossRef
Metadaten
Titel
Laparoscopic Total Mesorectal Excision for Extraperitoneal Rectal Cancer: Long-Term Results of a 18-Year Single-Centre Experience
verfasst von
Riccardo Brachet Contul
Manuela Grivon
Massimiliano Fabozzi
Paolo Millo
Mario Junior Nardi
Stefania Aimonetto
Umberto Parini
Rosaldo Allieta
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 4/2014
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-013-2441-9

Weitere Artikel der Ausgabe 4/2014

Journal of Gastrointestinal Surgery 4/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.